Raymond James Financial’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.6M Buy
461,943
+3,263
+0.7% +$377K 0.01% 895
2026
Q1
$54.8M Buy
458,680
+16,792
+4% +$2.2M 0.02% 806
2025
Q4
$60.2M Buy
441,888
+7,221
+2% +$1.04M 0.02% 736
2025
Q3
$64.1M Buy
434,667
+1,998
+0.5% +$277K 0.02% 665
2025
Q2
$56M Buy
432,669
+56,416
+15% +$6.83M 0.02% 703
2025
Q1
$44.9M Buy
376,253
+27,657
+8% +$3.43M 0.02% 776
2024
Q4
$40.4M Buy
+348,596
New +$44.1M 0.01% 850

Other funds holding XYL

Raymond James Financial's XYL Position: Q2 2026 in Review

Raymond James Financial increased its Xylem (XYL) stake by 0.71% in Q2 2026, buying an estimated $377K and bringing the position to 461,943 shares worth $54.6M. The position accounts for 0.01% of the portfolio, ranked #895.

Raymond James Financial first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $64.1M in Q3 2025. 1,102 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Raymond James Financial held 461,943 shares of Xylem worth $54.6M as of Q2 2026.
  • Raymond James Financial bought 3,263 Xylem shares in Q2 2026, an estimated $377K.
  • Xylem made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #895 holding.
  • Raymond James Financial first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Xylem position peaked at $64.1M in Q3 2025.
  • 1,102 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.